SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June, 2026.

SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited has responded to the National Stock Exchange's (NSE) query regarding a spurt in volume of its equity shares, stating that the company has been complying with all material event disclosures and has not withheld any price-sensitive information.

SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited has observed a significant increase in volume, prompting the exchange to write to the company for a response.

SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited has closed its trading window for insiders due to SEBI regulations, effective from July 1, 2026, until 48 hours after the declaration of Q1 FY2026-27 financial results.